BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Returning for the 6th year\, the Antifibrotic Drug Development
  Summit (AFDD) will host the transferrable insights you need from IPF\, N
 ASH\, CKD and more in one place at one time\, so you can advance the prog
 ress of your antifibrotic therapies.\n\nFrom exploring cellular mechanism
 s to identify a common fibrotic pathway to bridging the translational gap
  to prove early therapeutic effectiveness\; this unique cross-organ\, cro
 ss-disease\, cross-discipline discussion forum is here to transform your 
 fibrosis research.\n\nJoin 100+ industry super giants from Boehringer Ing
 elheim\, Genentech\, Gilead\, Pfizer\, Novartis\, and many more in Boston
  to harness the knowledge you need for your 2022/23 antifibrotic research
  and drug development.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/124106
 6-2?pid=185Brochure:&nbsp\;https://go.evvnt.com/1241066-3?pid=185\n\nPric
 es:Industry - Conference + Workshop Day (Earlybird rates available): USD 
 3946.00\,Industry - Conference Only (Earlybird rates available): USD 2599
 .00\,Academics - Conference + Workshop Day (Earlybird rates available): U
 SD 3246.00\,Academics - Conference Only (Earlybird rates available): USD 
 2199.00\,Solution Providers - Conference + Workshop Day (Earlybird rates 
 available): USD 5696.00\,Solution Providers - Conference Only (Earlybird 
 rates available): USD 3599.00\n\nSpeakers:&nbsp\;Adi Mor Chief Scientific
  Officer Chemomab\, Akshay Krishnamurty Senior Scientist\, Cancer Immunol
 ogy Genentech\, Andrew Leask Professor University of Saskatchewan\, Andrz
 ej Krolewski Senior Investigator Joslin Diabetes Centre\, Anissa Kalinows
 ki Chief Executive Officer Halo Biosciences\, Anjali Pandey Senior Vice P
 resident Nonclinical R&amp\;D and Chemistry ARIA Pharmaceuticals\, Anna Z
 argoska Senior Research Scientist II Gilead\, Cheryl Nickerson-Nutter Vic
 e President Research and Development Three Lakes Partners\, Christian Hes
 slinger Senior Expert Translational Medicine and Biomarker Boehringer Ing
 elheim\, Christina Wenglen Head of Research Anamar\, David Lagares Direct
 or and Head of Matrix and Mechanobiology Program Massachusetts General Ho
 spital\, Elizabeth Redente Associate Professor National Jewish Health\, E
 ric White Senior Clinical Program Lead Boehringer Ingelheim\, Geoffrey Te
 ixeira Head of Fibrosis Alentis Therapeutics\, Haig Aghajanian Co-Founder
  and Vice President - Research Capstan Therapeutics\, Harry Karmouty-Quin
 tana Associate Professor University of Texas\, Herman Steen Co-Founder an
 d Chief Executive Officer BiOrion Technologies\, Hind Lal Associate Profe
 ssor University of Alabama at Birmingham\, Ilya Korsunsky Instructor of M
 edicine Harvard Medical School\, Jeff Biernaskie Professor University of 
 Calgary\, Jeremy O'Connell Chief Scientific Officer and Co-Founder Juvena
  Therapeutics\, Ken Dower Senior Principal Scientist and Associate Fellow
  - Research Pfizer\, Kevin Wei Assistant Professor Harvard University\, L
 ee Borthwick Chief Operating Officer FibroFind\, Lindsay McDonald Assista
 nt Professor Medical University of South Carolina\, Michael Underhill Pro
 fessor University of British Columbia\, Morten Karsdal Chief Executive Of
 ficer Nordic Bioscience\, Peter Bunyard Head of Fibrosis Biology RedX Pha
 rma\, Philipp Tropberger Senior Principal Scientist Novartis\, Richard St
 ratton Consultant and Senior Lecturer University College London\, Rohan M
 anohar Associate Director - Discovery Biology Scholar Rock\, Ryan Feaver 
 Executive Director and Head of Exploratory Biology HemoShear\, Shannon Tu
 rley Vice President\, Immunology and OMNI Biomarker Discovery Genentech\,
  Thomas Fabre Senior Scientist Pfizer\, Will Richardson Assistant Profess
 or of Bioengineering University of Arizona\n
DTEND:20221111T170000
DTSTAMP:20260512T230910Z
DTSTART:20221109T082500
LOCATION:Crowne Plaza Boston - Woburn\, an IHG Hotel\, 15\, Middlesex Cana
 l Park Rd\, Middlesex County\, 01801\,
SEQUENCE:0
SUMMARY:Returning for the 6th year\, the Antifibrotic Drug Development Sum
 mit (AFDD) will host the transferrable insights you need from IPF\, NASH\
 , CKD and m...
UID:8282ac03-591b-4616-aeb5-3c83ffc360c5
END:VEVENT
END:VCALENDAR